Uses ultrasound scans to track psoriatic arthritis activity over time
Observes psoriatic arthritis patients using power Doppler ultrasound to assess joint inflammation.
Plain-language title generated from the registry record
Registry title: Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
Key facts
- Where
- Nanjing, ChinaSee the 2 sites
Where in China
- Department of Rheumatology and Immunology, Jiangsu Province HospitalNanjing, ChinaTaking people
- Jiangsu Province HospitalNanjing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Nanjing Medical University
- Trial code
- NCT06730334
- Record updated
- 20 December 2024
- Original description
Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, which complicates psoriasis in 30% of patients. PsA involves multiple tissues and clinical domains including skins and nails as well as arthritis, spondylitis, enthesitis, and dactylitis. Power Doppler (PD) ultrasonography (PDUS) is a sensitive non-invasive imaging technology used to assess disease activity and treatment response in PsA. This is a prospective, observational, open-label study to investigate disease activity, therapeutic response and bone destruction based on ultrasonography findings in patients with PsA.Read full original descriptionShow less
A Single Centre Prospective Cohort Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, which complicates psoriasis in 30% of patients. PsA involves multiple tissues and clinical domains including skins and nails as well as arthritis, spondylitis, enthesitis, and dactylitis. Power Doppler (PD) ultrasonography (PDUS) is a sensitive non-invasive imaging technology used to assess disease activity and treatment response in PsA. This is a prospective, observational, open-label study to investigate disease activity, therapeutic response and bone destruction based on ultrasonography findings in patients with PsA.
Inclusion: PsA patients as defined by CASPAR criteria; Patients must be able to comply with the visit schedule, treatment plan, laboratory tests and other study procedures; Patients must be given informed consent.
Exclusion: Concomitant disease with acute or chronic infectious diseases; History of other arthritis within the last 12 months; Pregnancy or laction; Poorly tolerated with venipuncture required for blood sampling during the study.